Nancy Lee
@imrtlee
Followers
3K
Following
695
Statuses
402
Vice Chair, Member, Mskcc Director of Head and Neck Cancer; Director of proton therapy
New York, NY
Joined October 2016
RT @HenningWillers: 1/2 March 1 already⁉️😅 🔥Absolute pleasure to be discussing BRCAness/HRD as a predictor of chemoradiosensitivity in #b…
0
6
0
RT @rbryanbell: I am deeply honored to succeed Dr. Urba & I am committed to building upon his legacy of transformational immuno-oncology r…
0
5
0
RT @MSK_RadOnc: New in @PhiroTweets: Quantitative imaging metrics correlated with rapid volume loss during #radiotherapy for head & neck ca…
0
6
0
RT @EChrisDee: 📜 In The #Laryngoscope, of #patients w #nasopharynx #cancer, stage 4 disease was most common among #Hmong, #PacificIslander,…
0
6
0
RT @CJTsaiMDPhD: Congrats on the publication of @NRGonc HN004. No benefit of concurrent IO-RT in the definitive treatment of HNSCC. https:/…
0
24
0
RT @seanmmcbride: Very pleased that @CMSGov followed the evidence and decided to continue to allow telehealth for status checks (77427). T…
0
7
0
RT @MSKCancerCenter: Last weekend, MSK radiation oncologist Dr. Nancy Lee (@imrtlee) presented on "Phase II Trial of Proton Re-Irradiation+…
0
8
0
@CJTsaiMDPhD @MSKCancerCenter @MSK_RadOnc @AMFShepherd @simonpowell213 @JYangMDPhD @ErinGillespieMD @IyengarPuneeth @gerryhanna Love this trial!
1
0
3
RT @CJTsaiMDPhD: ☢️🙌🏼Yes! Quad Shot is very versatile and can be used in NSCLC, HN, and other cancers. Congrats to @MSKCancerCenter @MSK_Ra…
0
8
0
@JTWeeSGP @CJTsaiMDPhD @sueyom @NRGonc @ASTRO_org Ditto about biomarker impotence. Only ctdna has issues intra treatment look for @BillDiplas @xrtGenomics paper
3
0
0
@NeilWoodyMD @CJTsaiMDPhD @sueyom @NRGonc @ASTRO_org Our phase 3 FDA registration multicenter trial using FMISO to guide and personalize RT to 30 vs 70 Gy for HPV positive tumors is accruing. Hopefully set a new standard for our field.
0
2
9
RT @seanmmcbride: @CJTsaiMDPhD @sueyom @NRGonc @ASTRO_org @imrtlee One additional potential takeaway is that if we’re going to de-escalate…
0
2
0
RT @safaviaa: To supplement the HN005 discussant at @ASTRO_org #astro2024, consider enrolling and referring patients for @US_FDA phase 3 tr…
0
3
0
RT @CJTsaiMDPhD: ‼️@sueyom presenting @NRGonc HN005 interim analysis @ASTRO_org #ASTRO24. Safe to say concurrent IO-RT (as of current field…
0
22
0
RT @safaviaa: Ph 2 multicenter trial of #hncsm #radonc proton re-RT from @imrtlee @MSK_RadOnc at @ASTRO_org #ASTRO2024 Pts w/ at least pri…
0
7
0
@DrewMoghanaki @NRGonc @KaramLab @finn_corinne Not surprised. I’ve been preaching this for years based on Javelin HN100 results. There is a subset that will have benefit from IO, including large HN fields and fractionated RT. @xrtGenomics knows who. Look for his work.
0
2
7
RT @DrewMoghanaki: The embargo has been lifted on the results for the LU-005 phase III randomized clinical trial for LS-SCLC. #ASTRO24 @NRG…
0
28
0